Inhalation CDMO Global Research Report 2024-2033: Integration of AI and ML Enhances Capabilities, Biopharmaceutical Inhalation Therapies Rapidly Expand, Patient-Centric Solutions Take Center Stage
25 avr. 2024 11h16 HE
|
Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Inhalation CDMO Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The inhalation CDMO market size has grown...
Rising Demand for Stability Testing Drives Growth in Pharmaceutical Analytical Testing Market 2023-2028
21 sept. 2023 06h53 HE
|
Research and Markets
Dublin, Sept. 21, 2023 (GLOBE NEWSWIRE) -- The "Pharmaceutical Analytical Testing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)" report has been added to ...
Global Pharmaceutical Analytical Testing Outsourcing Market Report to 2028: Featuring Alcami, Boston Analytical, Catalent and Eurofins Scientific Among Others
08 févr. 2023 10h58 HE
|
Research and Markets
Dublin, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The "Pharmaceutical Analytical Testing Outsourcing Market by Type (Active Pharmaceutical Ingredients, Additives, Finished Products), Service, End User, and...
Berkshire Sterile expands analytical testing and development services
19 déc. 2022 13h15 HE
|
Berkshire Sterile Manufacturing
Lee, MA, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Berkshire Sterile Manufacturing (BSM), a Massachusetts-based fill finish CDMO, recently purchased and validated three new analytical instruments to expand...
Emerald Health Therapeutics’ Subsidiary Northern Vine Receives International Government Approvals and Completes Import and Export of Cannabis Oils for Research & Development
10 oct. 2018 07h00 HE
|
Emerald Health Therapeutics Inc.
Northern Vine receives approval from Health Canada to export to USA and import isolated CBD from the Netherlands, Colombia and China, with corresponding national permits First known export of legal...
Emerald Health Therapeutics’ Wholly Owned Subsidiary Northern Vine to Participate in Series of Cannabis Testing Seminars Hosted by Thermo Fisher Scientific
09 oct. 2018 07h00 HE
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV:EMH; OTCQX:EMHTF) (“Emerald”) today announced that Northern Vine Canada Inc....
Emerald Health Therapeutics Completes Acquisition of Licensed Dealer Northern Vine Canada
15 août 2018 14h52 HE
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (Emerald) has completed the purchase of the remaining shares of Northern Vine...
Emerald Health Therapeutics Completes Full Acquisition of Licensed Dealer Northern Vine to Advance Product Innovation
19 juil. 2018 06h56 HE
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, July 19, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) (Emerald) has signed a definitive agreement (“Agreement”) to acquire the...
Singular Research Initiates Coverage On EVIO
25 avr. 2018 08h00 HE
|
EVIO, Inc.
BEND, Ore., April 25, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – EVIO, Inc. (OTCQB:EVIO) (“EVIO” or “the Company”), today announced that Singular Research has initiated analyst coverage on the...
EVIO Inc. Announces the Appointment of Ron Russak as Vice President of Operations
29 janv. 2018 08h30 HE
|
EVIO, Inc.
BEND, Ore., Jan. 29, 2018 (GLOBE NEWSWIRE) -- EVIO, Inc. (OTCQB:EVIO), a life sciences company and leading provider of quality control testing and advisory services for the regulated cannabis...